Inhaled corticosteroids for treating active lung disease in survivors of preterm birth
Phase of Trial: Phase IV
Latest Information Update: 15 May 2019
Price : $35 *
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Lung disorders
- Focus Therapeutic Use
- Acronyms PICSI
- 13 May 2019 Planned number of patients changed from 200 to 250.
- 13 May 2019 Status changed from not yet recruiting to recruiting.
- 23 Aug 2018 Planned initiation date changed from 29 Jun 2018 to 3 Sep 2018.